It is known that in multiple myeloma cell lines, the overexpression of miR-17-5p in association with Nrf2 influences ferroportin (FPN1) expression, as well as promotes cell proliferation, cell cycle progression and apoptosis inhibition [45]. This evidence concerns the gene NFE2L2 and plasma cell myeloma.